Saridegib (IPI-926) (Synonyms: IPI-926; Patidegib) |
رقم الكتالوجGC32978 |
Saridegib (IPI-926) هو مثبط قوي ومحدد لـ Smoothened (Smo) ، وهو بروتين عبر الغشاء للإشارة في مسار Hedgehog (Hh).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1037210-93-7
Sample solution is provided at 25 µL, 10mM.
Saridegib is a potent and specific inhibitor of Smoothened (Smo), a key signaling transmembrane protein in the Hedgehog (Hh) pathway.
Evidence from a genetically engineered mouse model of pancreatic cancer demonstrates that Saridegib (IPI-926) can deplete tumor-associated stromal tissue and increase intratumoral mean vessel density. These changes result in enhanced delivery of concurrently administered systemic agents, leading to a decreased tumor burden and prolonged survival in this mouse model[1].
[1]. Ko AH, et al. A Phase I Study of FOLFIRINOX Plus IPI-926, a Hedgehog Pathway Inhibitor, for Advanced Pancreatic Adenocarcinoma. Pancreas. 2016 Mar;45(3):370-5.
Average Rating: 5
(Based on Reviews and 20 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *